510(k) device
KIDScore D3
Vitrolife A/S · Embryo Image Assessment System, Assisted Reproduction (PBH, Class II) · First FDA decision Jul 19, 2019, newest Jul 19, 2019Infertility
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
1
Naming "KIDScore D3"
MAUDE reports
0
Brand "KIDScore D3", since 2015
PubMed studies
6
Mentioning "KIDScore D3"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing KIDScore D3
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- KIDScore D3510(k)
K182798 · Decided Jul 19, 2019 · 290 days after receipt
Device type: Embryo Image Assessment System, Assisted Reproduction (PBH) · Obstetrics & Gynecology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "KIDScore D3", any status and sponsor, newest update first.
- KIDScore D3 Clinical StudyCompleted
VitrolifeNot on our public-company list
NCT03740828 · 81 participants · Start Sep 20, 2016 · Primary completion Oct 12, 2017
Device: KIDScore D3 · For: Infertility
Sites: San Diego, California; San Francisco, California; Miami, Florida · 6 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "KIDScore D3", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PBH
1 reports: 1 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "KIDScore D3"[tiab]. The summary above synthesizes these.
- The KIDScoreࡊ D3 scoring system contributes to the prediction of embryonic development potential: A promising tool for screening high-quality embryos.
Zhou J, Li R, Zhou J, et al. · Zygote · 2022
- Parental dietary patterns and assisted reproductive technology outcomes including embryo morphokinetics: rotterdam periconception cohort.
Hojeij B, Schoenmakers S, van Rossem L, et al. · J Assist Reprod Genet · 2025
- Morphokinetic analysis of early human embryonic development and its relationship to endometriosis resection: a retrospective time-lapse study using the KIDScoreࡊ D3 and D5 implantation data algorithm.
Herbert SL, Staib C, Wallner T, et al. · Arch Gynecol Obstet · 2023
- Development and validation of deep learning based embryo selection across multiple days of transfer.
Theilgaard Lassen J, Fly Kragh M, Rimestad J, et al. · Sci Rep · 2023
- Pseudo contrastive labeling for predicting IVF embryo developmental potential.
Erlich I, Ben-Meir A, Har-Vardi I, et al. · Sci Rep · 2022
- Impact of letrozole co-treatment during ovarian stimulation on oocyte yield, embryo development, and live birth rate in women with normal ovarian reserve: secondary outcomes from the RIOT trial.
Bülow NS, Warzecha AK, Nielsen MV, et al. · Hum Reprod · 2023Randomized Controlled Trial, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code PBH.
- Magenta BlastFuture Fertility, Inc. · 510(k) 2026
- Embryo PredictAlife Health · 510(k) 2026
- Chloe BlastFairtility , Ltd. · 510(k) 2025
- Eeva SystemAuxogyn, Inc. · 510(k) 2014
- Eeva 2.0Auxogyn, Inc. · De Novo 2014
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.